Literature DB >> 9827562

Cardiac myocytes express mRNA for ten RGS proteins: changes in RGS mRNA expression in ventricular myocytes and cultured atria.

T Kardestuncer1, H Wu, A L Lim, E J Neer.   

Abstract

Regulators of G-protein signalling (RGS) are recently identified proteins that shorten the lifetime of the activated G protein. We now show that rat cardiac myocytes express mRNA for at least 10 RGS. The mRNA for RGS-r is barely detectable in rat ventricles, but increases more than 20-fold during the 60- to 90-min process of isolating ventricular myocytes, and after 90 min of culture of atrial pieces in medium with Ca2+. Both in myocytes and in atria, the rise in RGS-r is transient. The mRNA for cardiac RGS5, but not RGS-r, is developmentally regulated. These studies suggest that rapid regulation of RGS levels may be a new mechanism that governs how signals are transmitted across the cardiac cell membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827562     DOI: 10.1016/s0014-5793(98)01319-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Endogenous regulator of G-protein signaling proteins modify N-type calcium channel modulation in rat sympathetic neurons.

Authors:  S W Jeong; S R Ikeda
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

3.  Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses.

Authors:  Peng Zhang; Jialin Su; Michelle E King; Angel E Maldonado; Cindy Park; Ulrike Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-15       Impact factor: 4.733

4.  Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart.

Authors:  Khalid Chakir; Charlene Depry; Veronica L Dimaano; Wei-Zhong Zhu; Marc Vanderheyden; Jozef Bartunek; Theodore P Abraham; Gordon F Tomaselli; Shu-bai Liu; Yang K Xiang; Manling Zhang; Eiki Takimoto; Nickolai Dulin; Rui Ping Xiao; Jin Zhang; David A Kass
Journal:  Sci Transl Med       Date:  2011-09-14       Impact factor: 17.956

Review 5.  Structure, function, and localization of Gβ5-RGS complexes.

Authors:  Vladlen Z Slepak
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

6.  RGS6, but not RGS4, is the dominant regulator of G protein signaling (RGS) modulator of the parasympathetic regulation of mouse heart rate.

Authors:  Nicole Wydeven; Ekaterina Posokhova; Zhilian Xia; Kirill A Martemyanov; Kevin Wickman
Journal:  J Biol Chem       Date:  2013-12-06       Impact factor: 5.157

7.  RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.

Authors:  J H Rogers; P Tamirisa; A Kovacs; C Weinheimer; M Courtois; K J Blumer; D P Kelly; A J Muslin
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

8.  A role for RGS10 in beta-adrenergic modulation of G-protein-activated K+ (GIRK) channel current in rat atrial myocytes.

Authors:  Kirsten Bender; Parastoo Nasrollahzadeh; Mathias Timpert; Bing Liu; Lutz Pott; Marie-Cécile Kienitz
Journal:  J Physiol       Date:  2008-02-14       Impact factor: 5.182

9.  The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling.

Authors:  Hyeseon Cho; Kathleen Harrison; Owen Schwartz; John H Kehrl
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

10.  Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene.

Authors:  Sabine Stuebe; Thomas Wieland; Elisabeth Kraemer; Alexandra v Stritzky; Diana Schroeder; Sünje Seekamp; Andreas Vogt; Ching-Kang Chen; Monica Patten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.